JPRN-UMIN000026706尚未招募2 期
Carboplatin with nab-paclitaxel as first-line therapy in patients with advanced non-small-cell lung cancer and idiopathic interstitial pneumonias - Carboplatin with nab-paclitaxel as first-line therapy in patients with advanced non-small-cell lung cancer and idiopathic interstitial pneumonias
Kurashiki Central Hospital Department of Respiratory medicine0 个研究点目标入组 32 人开始时间: 2017年4月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) with interstitial pneumonias secondary to other conditions 2) with history of acute exacerbations of interstitial pneumonias within 3 months 3) with history of subacute exacerbations of interstitial pneumonias within 3 months 4) with usage of immunosuppressants 5) with peripheral neuropathy with Grade 2-4 6) with allergy to carboplatin, albumin, or taxane-based anticancer agents 7) with active infectious diseases 8) with active double cancers 9) with clinically important complications 10) with positivity of HBs antigen
研究者
相似试验
已完成
2 期
Carboplatin and nab-Paclitaxel as first-line treatment in patients with advanced non-small cell lung cancer with interstitial lung disease (HOT1302)on-small cell lung cancerJPRN-UMIN000012901Hokkaido Lung Cancer Clinical Study Group36
招募中
1 期
PhaseI/II study of carboplatin plus nab-paclitaxel plus bevacizumab administered to advanced non-squamous non-small cell lung cancer.advanced non-squamous non-small cell lung cancerJPRN-UMIN000013333agoya City West Medical Center35
已完成
2 期
Phase II study of Carboplatin plus nab-Paclitaxel for advanced non-small cell lung cancer patients with interstitial lung diseaseAdvanced non-small cell lung cancer with interstitial lung diseaseJPRN-UMIN000012989Kanagawa Cardiovascular and Respiratory Center90
已完成
1 期
Phase I/II trial of nab-Paclitaxel,Carboplatin,plus Bevacizumab chemotherapy for patients with advanced Non-Squamous Non-Small Cell Lung Cancer.Advanced Non-Squamous Non-Small Cell Lung CancerJPRN-UMIN000013201Cancer Institute Hospital of JFCR61
招募中
2 期
OGIK2102JPRN-jRCTs071220008Okamoto Isamu52
